High-Level Production of Recombinant Eukaryotic Proteins from Mammalian Cells Using Lentivirus.
Methods in Molecular Biology. 2021-01-01; : 83-104
DOI: 10.1007/978-1-0716-1406-8_4
Lire sur PubMed
Behiels E(1), Elegheert J(2).
Author information:
(1)Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000 Bordeaux, France.
(2)Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, Bordeaux, France. .
Mammalian protein expression systems are ideally suited for the high-level production of recombinant eukaryotic secreted and membrane proteins for structural biology applications. Here, we present genetic transduction of HEK293-derived cells using lentivirus as a robust and cost-efficient method for the rapid generation of stable expression cell lines. We describe the features of the lentiviral transfer plasmid pHR-CMV-TetO2, as well as detailed protocols for production of lentiviral particles, determination of functional lentiviral titer, infection of expression cells, culture and expansion of the resulting stable cell lines, their adaptation to adherent and suspension growth, and constitutive or inducible milligram-scale protein production. The typical lead-time for a full production run is ~3-4 weeks, with an anticipated yield of up to tens of milligrams of protein per liter of expression medium.